Metacrine Price on February 2, 2023
MTCRDelisted Stock | USD 0.49 0.00 0.00% |
If you're considering investing in Metacrine Stock, it is important to understand the factors that can impact its price. As of today, the current price of Metacrine stands at 0.49, as last reported on the 29th of November, with the highest price reaching 0.52 and the lowest price hitting 0.43 during the day. We have found twenty-seven technical indicators for Metacrine, which you can use to evaluate the volatility of the firm. Please verify Metacrine's Mean Deviation of 2.54, downside deviation of 3.7, and Risk Adjusted Performance of 0.0431 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Metacrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Metacrine |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
MTCR |
Based on monthly moving average Metacrine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Metacrine by adding Metacrine to a well-diversified portfolio.
Related Headline
Satsuma Pharmaceuticals Headline on 2nd of February 2023
Satsuma Pharmaceuticals to Participate in the Virtual SVB Se... by finance.yahoo.com
SOUTH SAN FRANCISCO, Calif., Feb. 02, 2023 -- Satsuma Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing STS101 nasal powder, a novel investigational therapeutic product candidate for the acute treatment of migraine, today announced that John Kollins, President and Chief Executive Officer, will deliver a company presentation during the SVB Securities Global Biopharma Conference, which is being held virtually Febr
Metacrine Valuation on February 2, 2023
It is possible to determine the worth of Metacrine on a given historical date. On February 2, 2023 Metacrine was worth 0.52 at the beginning of the trading date compared to the closed value of 0.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Metacrine stock. Still, in general, we apply an absolute valuation method to find Metacrine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Metacrine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Metacrine's related companies.
Open | High | Low | Close | Volume | |
0.51 | 0.53 | 0.51 | 0.52 | 300,561 | |
02/02/2023 | 0.52 | 0.53 | 0.50 | 0.52 | 1,039,586 |
0.51 | 0.52 | 0.50 | 0.51 | 391,047 |
Backtest Metacrine | | | Metacrine History | | | Metacrine Valuation | Previous | Next |
Metacrine Trading Date Momentum on February 2, 2023
On February 03 2023 Metacrine was traded for 0.51 at the closing time. The top price for the day was 0.52 and the lowest listed price was 0.50 . The trading volume for the day was 391 K. The trading history from February 3, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.92% . The trading delta at closing time against the current closing price is 5.77% . |
Metacrine Fundamentals Correlations and Trends
By evaluating Metacrine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Metacrine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Metacrine financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Metacrine Stock history
Metacrine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Metacrine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Metacrine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Metacrine stock prices may prove useful in developing a viable investing in Metacrine
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California. Metacrine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Metacrine Stock Technical Analysis
Metacrine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Metacrine Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Metacrine cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Metacrine November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Metacrine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Metacrine shares will generate the highest return on investment. By undertsting and applying Metacrine stock market strength indicators, traders can identify Metacrine entry and exit signals to maximize returns
Metacrine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Metacrine's price direction in advance. Along with the technical and fundamental analysis of Metacrine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Metacrine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0431 | |||
Jensen Alpha | 0.3179 | |||
Total Risk Alpha | (0.43) | |||
Sortino Ratio | 0.0154 | |||
Treynor Ratio | (0.14) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Metacrine Stock
If you are still planning to invest in Metacrine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Metacrine's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies |